Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

1.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.0K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

396
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
396
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

131
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
131
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

546
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
546
Censoring Survival Data01:09

Censoring Survival Data

251
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
251

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trends in methicillin-resistant Staphylococcus aureus detection-rates and antibiotic resistance profiles in a cancer hospital from 2015 to 2024.

BMC infectious diseases·2026
Same author

Simultaneous transformations of view and place coding across reference frames in the macaque brain.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Improvements in substance use and social determinants of health associated with hepatitis C treatment initiation and sustained virologic response in opioid treatment programs.

Addictive behaviors reports·2026
Same author

Disentangled Multi-Modal Learning of Histology and Transcriptomics for Cancer Characterization.

IEEE transactions on medical imaging·2026
Same author

Adolescent autoimmune encephalitis with dual positive anti-Drebrin and anti-mGluR2 antibodies: a case report.

Frontiers in immunology·2026
Same author

A biosynthetic gene cluster for three post-chorismate pathways in Arabidopsis.

Nature plants·2026

Related Experiment Video

Updated: Sep 17, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K

MDDC: An R and Python package for adverse event identification in pharmacovigilance data.

Anran Liu1, Raktim Mukhopadhyay1,2, Marianthi Markatou3,4

  • 1Department of Biostatistics, University at Buffalo, Buffalo, NY, 14214, USA.

Scientific Reports
|July 2, 2025
PubMed
Summary

This study introduces a new pattern discovery method, Modified Detecting Deviating Cells (MDDC), for identifying adverse events in medical products. The R and Python package aids in postmarketing surveillance and enhances drug safety monitoring.

Keywords:
Adverse eventsModified deviating data cells (MDDC) algorithmPattern discoveryPharmacovigilancePublic healthSoftware

More Related Videos

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K
An Analytical Tool-box for Comprehensive Biochemical, Structural and Transcriptome Evaluation of Oral Biofilms Mediated by Mutans Streptococci
11:09

An Analytical Tool-box for Comprehensive Biochemical, Structural and Transcriptome Evaluation of Oral Biofilms Mediated by Mutans Streptococci

Published on: January 25, 2011

17.9K

Related Experiment Videos

Last Updated: Sep 17, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K
An Analytical Tool-box for Comprehensive Biochemical, Structural and Transcriptome Evaluation of Oral Biofilms Mediated by Mutans Streptococci
11:09

An Analytical Tool-box for Comprehensive Biochemical, Structural and Transcriptome Evaluation of Oral Biofilms Mediated by Mutans Streptococci

Published on: January 25, 2011

17.9K

Area of Science:

  • Pharmacovigilance and Drug Safety
  • Computational Methods in Healthcare
  • Data Mining and Pattern Recognition

Background:

  • Medical product safety is a global health priority.
  • Spontaneous reporting systems (SRS) and pharmacovigilance databases are critical for postmarketing surveillance.
  • Existing methods for signal detection in pharmacovigilance have limitations.

Purpose of the Study:

  • To introduce a novel pattern discovery method, Modified Detecting Deviating Cells (MDDC), for identifying adverse events.
  • To provide an R and Python package implementing the MDDC method and associated utility functions.
  • To demonstrate the utility of the package using real-world data.

Main Methods:

  • Development of the Modified Detecting Deviating Cells (MDDC) algorithm.
  • Implementation of MDDC in an R and Python package.
  • Inclusion of a data generation function for grouped adverse events.
  • Analysis of real datasets from the Food and Drug Administration Adverse Event Reporting System (FAERS).

Main Results:

  • The developed R and Python package successfully implements the MDDC method.
  • The package facilitates the identification of potential adverse event signals.
  • Demonstrated application on FAERS data showcases the practical utility of the tool.

Conclusions:

  • The MDDC method and accompanying package offer a novel approach to postmarketing adverse event identification.
  • This tool can enhance the efficiency and accuracy of drug safety surveillance.
  • The package supports researchers and regulatory bodies in monitoring medical product safety.